Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2014

01-08-2014

The beneficial effects of postconditioning on no-reflow phenomenon after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction

Authors: Mei Dong, Nan Mu, Fangming Guo, Chuanhuan Zhang, Faxin Ren, Jianping Li, Zhigang Tao, Jun Yang, Guangping Li

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2014

Login to get access

Abstract

No-reflow phenomenon is a serious complication of percutaneous coronary intervention (PCI) which is closely related to the incidence of major adverse cardiovascular events. It has been demonstrated that Postconditioning (PostC) during primary PCI confers protection against ischemia–reperfusion injury and thus might reduce infarct size. However, whether PostC may exert its beneficial effects on acute myocardial infarction (AMI) patients by reducing no-reflow phenomenon is still unknown. Sixty two patients diagnosed with ST-elevation AMI were randomly assigned to study group (n = 32) or control group (n = 30). Blood samples were obtained and assayed for creatine kinase MB (CK-MB) and high-sensitive C-reactive protein (hs-CRP). Determinants of reflow, including final thrombolysis in myocardial infarction (TIMI) grade-3 flow, ST-segment resolution (STR), myocardial blush grades-3 (MBG-3) and corrected thrombolysis in myocardial infarction frame count (cTFC), were comparative between the two groups. Compared with control group, more patients in study group were identified as the final TIMI grade-3 flow (81.3 vs. 56.7 %, P = 0.036), MBG-3 (23 vs. 14 %, P = 0.043) and STR ≥50 % (93.8 vs. 73.3 %, P = 0.029), while patients in study group had less cTFC (28.5 ± 9.1 vs. 37.4 ± 12.4, P = 0.002) After PCI, study group was associated with lower levels of CK-MB (2,397.6 ± 470.2 vs. 2,159.9 ± 485.5, P = 0.028), Troponin-I (197.5 ± 32.5 vs. 154 ± 43.1, P = 0.041) and hs-CRP (5.5 ± 4.5 vs. 9.5 ± 5.2 mg/L, P = 0.019) in comparison with control group. Left ventricle ejection fraction was better in the study group than in the control group (55.1 ± 9.8 vs. 42.9 ± 10.7, P = 0.042). PostC could improve myocardial reperfusion in patients with ST-elevation AMI undergoing PCI by reducing no-reflow. However, due to the limited sample size, the results of our study should not be considered conclusive.
Literature
1.
go back to reference Atary JZ, de Visser M, van den Dijk R, Bosch J, Liem SS et al (2010) Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J 18:408–415PubMedCentralPubMedCrossRef Atary JZ, de Visser M, van den Dijk R, Bosch J, Liem SS et al (2010) Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J 18:408–415PubMedCentralPubMedCrossRef
2.
go back to reference Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 361:13–20PubMedCrossRef Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 361:13–20PubMedCrossRef
3.
go back to reference Dong-bao L, Qi H, Zhi L, Shan W, Wei-ying J (2010) Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. Clin Cardiol 33:E7–E12PubMedCrossRef Dong-bao L, Qi H, Zhi L, Shan W, Wei-ying J (2010) Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. Clin Cardiol 33:E7–E12PubMedCrossRef
5.
go back to reference Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J et al (2000) Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36:1202–1209PubMedCrossRef Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J et al (2000) Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36:1202–1209PubMedCrossRef
6.
go back to reference Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV et al (2003) No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 145:42–46PubMedCrossRef Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV et al (2003) No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 145:42–46PubMedCrossRef
7.
go back to reference Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T et al (2002) Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106:1672–1677PubMedCrossRef Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T et al (2002) Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106:1672–1677PubMedCrossRef
8.
go back to reference Kaufmann PA, Camici PG (2005) Myocardial blood flow by PET: technical aspects and clinical applications. J Nucl Med 46:75–88PubMed Kaufmann PA, Camici PG (2005) Myocardial blood flow by PET: technical aspects and clinical applications. J Nucl Med 46:75–88PubMed
9.
go back to reference Penna C, Mancardi D, Raimondo S, Geuna S, Pagliaro P (2008) The paradigm of postconditioning to protect the heart. J Cell Mol Med 12:435–458PubMedCrossRef Penna C, Mancardi D, Raimondo S, Geuna S, Pagliaro P (2008) The paradigm of postconditioning to protect the heart. J Cell Mol Med 12:435–458PubMedCrossRef
10.
go back to reference Yetgin T, Manintveld OC, Duncker DJ, van der Giessen WJ (2010) Postconditioning against ischaemia-reperfusion injury: ready for wide application in patients? Neth Heart J. 18:389–392PubMedCentralPubMedCrossRef Yetgin T, Manintveld OC, Duncker DJ, van der Giessen WJ (2010) Postconditioning against ischaemia-reperfusion injury: ready for wide application in patients? Neth Heart J. 18:389–392PubMedCentralPubMedCrossRef
11.
go back to reference Yang XC, Liu Y, Wang LF, Cui L, Wang T et al (2007) Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 19:424–430PubMed Yang XC, Liu Y, Wang LF, Cui L, Wang T et al (2007) Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 19:424–430PubMed
12.
go back to reference The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 312:932–936CrossRef The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 312:932–936CrossRef
13.
go back to reference Daneault B, Do DH, Maltais A, Bérubé S, Harvey R et al (2011) Reduction of delays in primary percutaneous coronary intervention. Can J Cardiol 27:562–566PubMedCrossRef Daneault B, Do DH, Maltais A, Bérubé S, Harvey R et al (2011) Reduction of delays in primary percutaneous coronary intervention. Can J Cardiol 27:562–566PubMedCrossRef
14.
go back to reference McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR et al (1996) Recent trials in acute coronary disease: mortality, morbidity, medical care and risk factors: the Minnesota Heart Survey investigators. N Eng J Med 334:884–890CrossRef McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR et al (1996) Recent trials in acute coronary disease: mortality, morbidity, medical care and risk factors: the Minnesota Heart Survey investigators. N Eng J Med 334:884–890CrossRef
15.
go back to reference Braunwald E (1989) Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded? Circulation 79:441–444PubMedCrossRef Braunwald E (1989) Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction and improved survival. Should the paradigm be expanded? Circulation 79:441–444PubMedCrossRef
17.
go back to reference Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS et al (2004) Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62:74–85PubMedCrossRef Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS et al (2004) Postconditioning attenuates myocardial ischemia–reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62:74–85PubMedCrossRef
18.
go back to reference Yang XM, Proctor JB, Cui L, Krieg T, Downey JM et al (2004) Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44:1103–1110PubMedCrossRef Yang XM, Proctor JB, Cui L, Krieg T, Downey JM et al (2004) Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44:1103–1110PubMedCrossRef
19.
go back to reference Staat P, Rioufol G, Piot C, Cottin Y, Cung TT et al (2005) Postconditioning the human heart. Circulation 112:2143–2148PubMedCrossRef Staat P, Rioufol G, Piot C, Cottin Y, Cung TT et al (2005) Postconditioning the human heart. Circulation 112:2143–2148PubMedCrossRef
20.
go back to reference Lønborg J, Kelbaek H, Vejlstrup N, Jørgensen E, Helqvist S et al (2010) Cardioprotective effects of local ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 3:34–41PubMedCrossRef Lønborg J, Kelbaek H, Vejlstrup N, Jørgensen E, Helqvist S et al (2010) Cardioprotective effects of local ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 3:34–41PubMedCrossRef
21.
go back to reference Xue F, Yang X, Zhang B, Zhao C, Song J et al (2010) Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 33:439–444PubMedCrossRef Xue F, Yang X, Zhang B, Zhao C, Song J et al (2010) Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 33:439–444PubMedCrossRef
22.
go back to reference Laskey WK (2005) Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 65:361–367PubMedCrossRef Laskey WK (2005) Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 65:361–367PubMedCrossRef
23.
go back to reference Ma X, Zhang X, Li C, Luo M (2006) Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol 19:367–375PubMedCrossRef Ma X, Zhang X, Li C, Luo M (2006) Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol 19:367–375PubMedCrossRef
24.
go back to reference Thibault H, Piot C, Staat P, Bontemps L, Sportouch C et al (2008) Long-term benefit of postconditioning. Circulation 117:1037–1044PubMedCrossRef Thibault H, Piot C, Staat P, Bontemps L, Sportouch C et al (2008) Long-term benefit of postconditioning. Circulation 117:1037–1044PubMedCrossRef
25.
go back to reference Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G et al (2012) Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 59:2175–2181PubMedCrossRef Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G et al (2012) Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 59:2175–2181PubMedCrossRef
26.
go back to reference Sörensson P, Saleh N, Bouvier F, Böhm F, Settergren M et al (2010) Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 96:1710–1715PubMedCrossRef Sörensson P, Saleh N, Bouvier F, Böhm F, Settergren M et al (2010) Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 96:1710–1715PubMedCrossRef
27.
go back to reference Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765–772PubMedCrossRef Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA et al (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765–772PubMedCrossRef
28.
go back to reference Tomaszuk-Kazberuk A, Sobkowicz B, Kaminski K, Gugala K, Mezynski G et al (2008) Myocardial perfusion assessed by contrast echocardiography correlates with angiographic perfusion parameters in patients with a first acute myocardial infarction successfully treated with angioplasty. Can J Cardiol 24:633–639PubMedCentralPubMedCrossRef Tomaszuk-Kazberuk A, Sobkowicz B, Kaminski K, Gugala K, Mezynski G et al (2008) Myocardial perfusion assessed by contrast echocardiography correlates with angiographic perfusion parameters in patients with a first acute myocardial infarction successfully treated with angioplasty. Can J Cardiol 24:633–639PubMedCentralPubMedCrossRef
29.
go back to reference Almansori M, Armstrong P, Fu Y, Kaul P (2010) Electrocardiographic identification of the culprit coronary artery in inferior wall ST elevation myocardial infarction. Can J Cardiol 26:293–296PubMedCentralPubMedCrossRef Almansori M, Armstrong P, Fu Y, Kaul P (2010) Electrocardiographic identification of the culprit coronary artery in inferior wall ST elevation myocardial infarction. Can J Cardiol 26:293–296PubMedCentralPubMedCrossRef
30.
go back to reference Santoro GM, Valenti R, Buonamici P, Bolognese L, Cerisano G et al (1998) Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 82:932–937PubMedCrossRef Santoro GM, Valenti R, Buonamici P, Bolognese L, Cerisano G et al (1998) Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 82:932–937PubMedCrossRef
31.
go back to reference Tomaszuk-Kazberuk A, Kozuch M, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S et al (2011) Does lack of ST-segment resolution still have prognostic value 6 years after an acute myocardial infarction treated with coronary intervention? Can J Cardiol 27:573–580PubMedCrossRef Tomaszuk-Kazberuk A, Kozuch M, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S et al (2011) Does lack of ST-segment resolution still have prognostic value 6 years after an acute myocardial infarction treated with coronary intervention? Can J Cardiol 27:573–580PubMedCrossRef
32.
go back to reference Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ et al (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1:415–423PubMedCrossRef Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ et al (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1:415–423PubMedCrossRef
33.
go back to reference Couvreur N, Lucats L, Tissier R, Bize A, Berdeaux A et al (2008) Differential effects of postconditioning on myocardial stunning and infarction:a study in conscious dogs and anesthetized rabbits. Am J Physiol Heart Circ Physiol 291:H1345–H1350CrossRef Couvreur N, Lucats L, Tissier R, Bize A, Berdeaux A et al (2008) Differential effects of postconditioning on myocardial stunning and infarction:a study in conscious dogs and anesthetized rabbits. Am J Physiol Heart Circ Physiol 291:H1345–H1350CrossRef
35.
go back to reference Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733PubMedCrossRef Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733PubMedCrossRef
36.
go back to reference Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP et al (2001) Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104:992–997PubMedCrossRef Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP et al (2001) Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104:992–997PubMedCrossRef
Metadata
Title
The beneficial effects of postconditioning on no-reflow phenomenon after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction
Authors
Mei Dong
Nan Mu
Fangming Guo
Chuanhuan Zhang
Faxin Ren
Jianping Li
Zhigang Tao
Jun Yang
Guangping Li
Publication date
01-08-2014
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2014
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-013-1010-0

Other articles of this Issue 2/2014

Journal of Thrombosis and Thrombolysis 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.